Ning Ran

799 total citations
15 papers, 600 citations indexed

About

Ning Ran is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ning Ran has authored 15 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Ning Ran's work include Muscle Physiology and Disorders (7 papers), Extracellular vesicles in disease (6 papers) and RNA Interference and Gene Delivery (3 papers). Ning Ran is often cited by papers focused on Muscle Physiology and Disorders (7 papers), Extracellular vesicles in disease (6 papers) and RNA Interference and Gene Delivery (3 papers). Ning Ran collaborates with scholars based in China, Singapore and United Kingdom. Ning Ran's co-authors include HaiFang Yin, Xianjun Gao, Xue Dong, Yiqi Seow, Bingfeng Zuo, Hong M. Moulton, Rong Yang, Qibing Zhou, Caorui Lin and Mengyuan Geng and has published in prestigious journals such as Biomaterials, Gut and Science Translational Medicine.

In The Last Decade

Ning Ran

14 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ning Ran China	10	517	206	79	52	46	15	600
Milad Riazifar United States	4	646 1.2×	342 1.7×	62 0.8×	74 1.4×	64 1.4×	4	771
Byong Seung Cho South Korea	6	561 1.1×	231 1.1×	47 0.6×	59 1.1×	71 1.5×	8	753
Xuefeng Hu China	15	373 0.7×	70 0.3×	43 0.5×	43 0.8×	66 1.4×	39	577
Camilla Paoletti Italy	8	382 0.7×	252 1.2×	65 0.8×	39 0.8×	90 2.0×	13	529
Yanfeng Wu China	13	288 0.6×	274 1.3×	37 0.5×	27 0.5×	63 1.4×	30	516
Ola A. Elgamal United States	9	662 1.3×	407 2.0×	63 0.8×	71 1.4×	57 1.2×	15	751
Louis J. Born United States	10	463 0.9×	162 0.8×	66 0.8×	53 1.0×	83 1.8×	24	642
Mingjuan Qu China	9	196 0.4×	81 0.4×	84 1.1×	50 1.0×	70 1.5×	16	419
Tim Davies United Kingdom	4	922 1.8×	309 1.5×	95 1.2×	76 1.5×	67 1.5×	5	1.0k

Countries citing papers authored by Ning Ran

Since Specialization

Citations

This map shows the geographic impact of Ning Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Ran more than expected).

Fields of papers citing papers by Ning Ran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Ran. The network helps show where Ning Ran may publish in the future.

Co-authorship network of co-authors of Ning Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Ran. A scholar is included among the top collaborators of Ning Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Ran. Ning Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Fan, Baoyou, Xiang Gao, Xiaoyang Chen, et al.. (2025). Targeted delivery of the GPX4 activator via HUCMSC-derived exosomes inhibits ferroptosis in spinal cord injury. Journal of Nanobiotechnology. 23(1). 707–707.

Lin, Caorui, Ying Huang, Ning Ran, et al.. (2025). Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α. Gut. 74(12). 2035–2049. 1 indexed citations

Zhang, Jianping, Han Ding, Wenxiang Li, et al.. (2024). Nicotinamide Riboside Promotes the Proliferation of Endogenous Neural Stem Cells to Repair Spinal Cord Injury. Stem Cell Reviews and Reports. 20(7). 1854–1868. 3 indexed citations

Li, Zonghao, Han Zheng, Wenxiang Li, et al.. (2024). New strategy to treat spinal cord injury: Nafamostat mesilate suppressed NLRP3-mediated pyroptosis during acute phase. International Immunopharmacology. 134. 112190–112190. 1 indexed citations

Li, Wenxiang, Xiaoqing Zhao, Rong Zhang, et al.. (2023). Ferroptosis inhibition protects vascular endothelial cells and maintains integrity of the blood-spinal cord barrier after spinal cord injury. Neural Regeneration Research. 18(11). 2474–2481. 18 indexed citations

Lin, Caorui, Linjie Luo, Zhen Xun, et al.. (2023). Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infection. Gut. 73(2). 338–349. 9 indexed citations

Ran, Ning, Renjie Zhang, Caorui Lin, et al.. (2022). Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury. Bioactive Materials. 25. 766–782. 51 indexed citations

Lin, Caorui, Gang Han, Lulu Jia, et al.. (2022). Cardio‐respiratory and phenotypic rescue of dystrophin/utrophin‐deficient mice by combination therapy. EMBO Reports. 23(6). e53955–e53955. 4 indexed citations

Ran, Ning, Xianjun Gao, Xue Dong, et al.. (2020). Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice. Biomaterials. 236. 119826–119826. 82 indexed citations

10.

Leng, Ling, Xue Dong, Xianjun Gao, et al.. (2020). Exosome-mediated improvement in membrane integrity and muscle function in dystrophic mice. Molecular Therapy. 29(4). 1459–1470. 24 indexed citations

11.

Lin, Caorui, Gang Han, Ning Ran, et al.. (2020). Glycine Enhances Satellite Cell Proliferation, Cell Transplantation, and Oligonucleotide Efficacy in Dystrophic Muscle. Molecular Therapy. 28(5). 1339–1358. 31 indexed citations

12.

Ran, Ning, Caorui Lin, Ling Leng, et al.. (2020). MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice. EMBO Molecular Medicine. 13(2). e12993–e12993. 10 indexed citations

13.

Dong, Xue, Xianjun Gao, Yi Dai, Ning Ran, & HaiFang Yin. (2018). Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy. Theranostics. 8(5). 1243–1255. 19 indexed citations

14.

Gao, Xianjun, Ning Ran, Xue Dong, et al.. (2018). Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy. Science Translational Medicine. 10(444). 326 indexed citations

15.

Gao, Xianjun, Xiaoyong Shen, Xue Dong, et al.. (2015). Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice. Molecular Therapy — Nucleic Acids. 4. e255–e255. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact